To view this email as a web page, click here.
 
FDA issues warning for certain hepatitis C drugs
FDA is warning that certain chronic hepatitis C medications in patients with moderate to severe liver impairment have caused rare cases of worsening liver function or liver failure.
Read more
 
FDA clears Parkinson’s add-on treatment
FDA cleared a new add-on treatment to levodopa/carbidopa for patients with Parkinson’s disease experiencing "off" episodes.
Read more
 
Four things to know about providing CAR T-cell treatment
From our sister publication, Drug Topics: Experts reveal the top 4 things to know about providing CAR T-cell treatment.
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.